Relationship Between Level of Simple Carbohydrate and Trans Fat Intake with Severity of Coronary Artery Stenosis Based on Gensini Score at Kariadi Hospital Semarang
DOI:
https://doi.org/10.36408/mhjcm.v12i3.1374Keywords:
Coronary Artery Disease, Gensini Score, Simple Carbohydrates, Trans FatsAbstract
BACKGROUND: Coronary artery disease accounts for 111 million (27%) out of 400 million cases of cardiovascular disease worldwide. Regular consumption of foods high in trans fats and simple carbohydrates is a major cause of increased blood lipid and glucose levels, which are key risk factors for coronary artery disease.
AIMS: This researches to examine the relationship between the amount of simple carbohydrate and trans fat intake and the severity of coronary artery stenosis based on the Gensini score.
METHODS: This research used a cross-sectional observational design involving 56 patients with chronic coronary syndrome who had undergone coronary angiography and were found to have stenosis in their coronary arteries. The parameters assessed included the amount of simple carbohydrate intake, trans fat intake, LDL levels, HDL levels, triglyceride levels, HbA1C levels, hs-CRP levels, oxLDL levels, and Gensini score.
RESULTS: There was a significant relationship between the amount of simple carbohydrate intake and the severity of coronary artery stenosis based on the Gensini score (p=0.004), and between the amount of trans fat intake and the severity of coronary artery stenosis based on the Gensini score (p=0.02). Additionally, there was a significant relationship between trans fat levels and LDL levels (p=0.017), and oxLDL levels (p=0.014), but not with HDL, triglyceride, or hs-CRP levels (p>0.05). Confounding variables such as age, gender, socioeconomic status, body mass index, hypertension, diabetes mellitus, dyslipidemia, statin use, antidiabetic drug use, physical activity, and statin use showed no significant relationship (p>0.05).
CONCLUSION: There is a significant relationship between the amount of simple carbohydrate and trans fat intake and the severity of coronary artery stenosis based on the Gensini score.
Downloads
References
1. Upadhyay RK. Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids. 2015:1–50.
2. World Health Organization. Global status report on noncommunicable diseases 2014. World Health Organization (2014). 26 October 2014. https://www.who.int/publications/i/item/9789241564854
3. Sosial Ekonomi Nasional (Susenas) BPS. Badan Pusat Statistik. 2021. 6 April 2021. https://www.kompas.id/artikel/gula-menjadi-candu-bagi-orang-indonesia/amp
4. Celik A, Karayakali M, Erkorkmaz U, et al. Presence of angina pectoris is related to extensive coronary artery disease in diabetic patients. Clin Cardiol 2013;36:475–9.
5. Cosentino F, Rydén L, Francia P. Camm AJ, Lüscher TF, Serruys PW, et al. Diabetes mellitus and metabolic syndrome. ESC Textbook of Cardiovascular Medicine 2nd ed. New York, NY: Oxford University Press; 2009;465–96
6. Avci A, Fidan S, Tabakçı MM, Toprak C, Alizade E, Acar E, et al Association between the Gensini Score and Carotid artery stenosis. Korean Circ J. 2016; 46(5): 639-45
7. Ahmad F, Ichsan T, Andi M, Asrul I, Sanya A, Elma A, Lusi A. Et al. Survei Konsumsi Gizi. Yayasan Kita Menulis.2022;1-3
8. Faridi A, Trisutrisno I, Irawan A, Muh A. Adni T, Ganesha, et al. Survei Konsumsi Gizi. April 2022; 33-54
9. Georgios P, Rampidis, Georgios B, Dominik C, Andreas A, Giannopoulos, et al. A guide for Gensini Score Calculation. Atherosclerosis Journal. 2019; 181-183
10. Roma P, Ishwarlal J, Dichgans M, Pulit S, Rosand J, Mohd N, et al. Atheroscleosis. National Institute of Health. August 2024.
11. Peter L, Robert O, Douglas L, Gordon F, Deepak B, Scott D, et al. Braunwald’s Heart Disease: A Textbook Of Cardiovascular Medicine, Twelfth Edition. Elservier. 2022: 427-445
12. Holesh JE, Aslam S, Martin A. Physiology, Carbohydrates. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan; 611-27
13. Hadj A, Kharroubi W, Kaoubaa N, Zarrouk A, Batbout F, Gamra H, et al. Correlation of trans fatty acids with the severity of coronary artery disease lesions. Lipids Health Dis. 2018 Mar 15;17(1):52
14. Singh R, Ram D, Suniti D, Fabien J, Lekh P, Daniel, et al. Role of Cardioprotective Diet in Acute Coronary Syndrome. Amer. Med. Journal. 2011. 2: 98-103.
15. Sacks FM, Lichtenstein AH, Wu JHY, Appel LJ, Creager MA, Kris-Etherton PM, et al. American Heart Association. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation 2017;136:e1–e23.
16. Frank L, François M, Yvo M, David C, Konstantinos C, Maria B, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal. Volume 42, Issue 34, 7 September 2021; 3227–3337
17. Rainer G, Dorothee V, Anne M, Tommy C, Alfonso C, Sabine G, et al. Nutrition Survery and Calculations. Oct 29th, 2007;494–499
18. Brouwer IA, Wanders AJ, Katan MB. Trans fatty acids and cardiovascular health: research completed. Eur J Clin Nutr.2013;67:541–547.
19. Gebauer SK, Destaillats F, Dionisi F, Krauss RM, Baer DJ. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. Am J Clin Nutr. 2015;102:1339–1346.
20. Stender S. In equal amounts, the major ruminant trans fatty acid is as bad for LDL cholesterol as industrially produced trans fatty acids, but the latter are easier to remove from foods. Am J Clin Nutr. 2015;102:1301–1302.
21. Libbi, et al. Braunwald’s Heart Disease: A Textbook Of Cardiovascular Medicine, Twelfth Edition. Elservier. 2022: 427-445
22. Faridi Ahmad, Trisutrisno Ichsan, et al. Survei Konsumsi Gizi. April 2022; 33-54
23. Frank L J Visseren, François Mach, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal. Volume 42, Issue 34, 7 September 2021; 3227–3337
24. Vrints, C., Andreotti, F., Koskinas, K. C., et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal, 2024;45(36), 3415–3537.
25. Aksu, F., et al. Gensini Score’s Severity and Its Relationship with Risk Factors for Coronary Artery Disease Among Patients Who Underwent Angiography in Somalia’s Largest PCI Centre. International Journal of General Medicine, Volume 17,2024; 187–192.
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2025 Yudhanta Suryadilaga, Sodiqur Rifqi, Sefri Noventi Sofia, Niken Puruhita, Suhartono Suhartono (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.
